HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
People

Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen

AI heavyweight Anthropic has appointed Novartis CEO Vas Narasimhan to its board of directors as the link between the pharmaceutical industry and Silicon Valley deepens.

By FiercePharma · Apr 17, 2026 · via FiercePharma
Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen

Image: FiercePharma

This is an aggregated industry headline. Read the full story at FiercePharma →

Tags
peopleformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from People
All People →
After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report
PeopleFiercePharma ↗
After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report
With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be head…
May 18, 2026
UPDATED: After Makary departure, CDER chief Tracy Beth Høeg headed out at FDA
PeopleFierceBiotech ↗
UPDATED: After Makary departure, CDER chief Tracy Beth Høeg headed out at FDA
With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator is heading …
May 17, 2026
Takeda, slimming down for 'new era,' plots 4,500 layoffs in latest restructuring drive
PeopleFiercePharma ↗
Takeda, slimming down for 'new era,' plots 4,500 layoffs in latest restructuring drive
Takeda's multiyear slim-down is expected to hit about 4,500 roles during the 2026 fiscal year, resulting in ab…
May 17, 2026